These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 30981650)

  • 21. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
    Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
    J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual-Affinity Re-Targeting proteins direct T cell-mediated cytolysis of latently HIV-infected cells.
    Sung JA; Pickeral J; Liu L; Stanfield-Oakley SA; Lam CY; Garrido C; Pollara J; LaBranche C; Bonsignori M; Moody MA; Yang Y; Parks R; Archin N; Allard B; Kirchherr J; Kuruc JD; Gay CL; Cohen MS; Ochsenbauer C; Soderberg K; Liao HX; Montefiori D; Moore P; Johnson S; Koenig S; Haynes BF; Nordstrom JL; Margolis DM; Ferrari G
    J Clin Invest; 2015 Nov; 125(11):4077-90. PubMed ID: 26413868
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dendritic Cells, the Double Agent in the War Against HIV-1.
    Martín-Moreno A; Muñoz-Fernández MA
    Front Immunol; 2019; 10():2485. PubMed ID: 31708924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Honing the T cell response to HIV: Turning off the noise.
    Landau NR
    EBioMedicine; 2021 Feb; 64():103217. PubMed ID: 33516065
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
    Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
    Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thalidomide as a Potential HIV Latency Reversal Agent: Is It the Right Time to Forget the Ancestral Sins?
    Vignesh R; Shankar EM
    EBioMedicine; 2017 Oct; 24():20-21. PubMed ID: 28865747
    [No Abstract]   [Full Text] [Related]  

  • 27. Chimeric immune receptor T cells bypass class I requirements and recognize multiple cell types relevant in HIV-1 infection.
    Severino ME; Sarkis PT; Walker BD; Yang OO
    Virology; 2003 Feb; 306(2):371-5. PubMed ID: 12642109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4(+) T-cells.
    Kumar NA; Cheong K; Powell DR; da Fonseca Pereira C; Anderson J; Evans VA; Lewin SR; Cameron PU
    Retrovirology; 2015 Sep; 12():76. PubMed ID: 26362311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Which therapeutic strategy will achieve a cure for HIV-1?
    Cillo AR; Mellors JW
    Curr Opin Virol; 2016 Jun; 18():14-9. PubMed ID: 26985878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Toward HIV eradication or remission: the tasks ahead.
    Ho DD
    Science; 1998 Jun; 280(5371):1866-7. PubMed ID: 9669944
    [No Abstract]   [Full Text] [Related]  

  • 32. AIDS/HIV. Rekindled HIV infection.
    Siliciano JD; Siliciano RF
    Science; 2014 Aug; 345(6200):1005-6. PubMed ID: 25170139
    [No Abstract]   [Full Text] [Related]  

  • 33. Productive human immunodeficiency virus type 1 infection in peripheral blood predominantly takes place in CD4/CD8 double-negative T lymphocytes.
    Kaiser P; Joos B; Niederöst B; Weber R; Günthard HF; Fischer M
    J Virol; 2007 Sep; 81(18):9693-706. PubMed ID: 17609262
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV persistence: chemokines and their signalling pathways.
    Evans VA; Khoury G; Saleh S; Cameron PU; Lewin SR
    Cytokine Growth Factor Rev; 2012; 23(4-5):151-7. PubMed ID: 22749173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HIV immunotherapy comes of age: implications for prevention, treatment and cure.
    Routy JP; Mehraj V; Cao W
    Expert Rev Clin Immunol; 2016; 12(2):91-4. PubMed ID: 26629806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Advancements in Developing Strategies for Sterilizing and Functional HIV Cures.
    Xu W; Li H; Wang Q; Hua C; Zhang H; Li W; Jiang S; Lu L
    Biomed Res Int; 2017; 2017():6096134. PubMed ID: 28529952
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Transcriptional Reprogramming during Effector-to-Memory Transition Renders CD4
    Shan L; Deng K; Gao H; Xing S; Capoferri AA; Durand CM; Rabi SA; Laird GM; Kim M; Hosmane NN; Yang HC; Zhang H; Margolick JB; Li L; Cai W; Ke R; Flavell RA; Siliciano JD; Siliciano RF
    Immunity; 2017 Oct; 47(4):766-775.e3. PubMed ID: 29045905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic Targeting of HIV Reservoirs: How to Give T Cells a New Direction.
    Yang H; Wallace Z; Dorrell L
    Front Immunol; 2018; 9():2861. PubMed ID: 30564246
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of human immunodeficiency virus type 1 replication in primary CD4(+) T lymphocytes, monocytes, and dendritic cells by cytotoxic T lymphocytes.
    Severino ME; Sipsas NV; Nguyen PT; Kalams SA; Walker BD; Johnson RP; Yang OO
    J Virol; 2000 Jul; 74(14):6695-9. PubMed ID: 10864688
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
    Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
    J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.